LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 104 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $7,000 | -50.0% | 3,625 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $14,000 | -17.6% | 3,625 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $17,000 | +6.2% | 3,625 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $16,000 | -90.2% | 3,625 | -87.0% | 0.00% | -93.8% |
| Q1 2021 | $164,000 | +13.1% | 27,942 | -20.1% | 0.02% | +14.3% |
| Q4 2019 | $145,000 | +59.3% | 34,976 | +306.2% | 0.01% | +133.3% |
| Q3 2018 | $91,000 | +26.4% | 8,610 | +95.5% | 0.01% | -14.3% |
| Q2 2017 | $72,000 | -65.2% | 4,403 | -70.6% | 0.01% | -69.6% |
| Q4 2016 | $207,000 | +3.5% | 14,988 | +7.1% | 0.02% | +9.5% |
| Q2 2016 | $200,000 | +34.2% | 13,999 | +12.3% | 0.02% | -12.5% |
| Q1 2016 | $149,000 | +396.7% | 12,470 | +447.2% | 0.02% | +380.0% |
| Q4 2015 | $30,000 | – | 2,279 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $14,779,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $243,430,000 | 5.23% |
| BVF INC/IL | 10,963,000 | $37,493,000 | 1.48% |
| Integral Health Asset Management, LLC | 300,000 | $1,026,000 | 0.30% |
| NEA Management Company, LLC | 2,382,286 | $8,147,000 | 0.22% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $122,000 | 0.13% |
| PINNACLE ASSOCIATES LTD | 1,852,382 | $6,335,000 | 0.13% |
| XTX MARKETS LLC | 13,242 | $45,000 | 0.09% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 828,192 | $2,832,000 | 0.06% |
| WINTON GROUP Ltd | 192,890 | $660,000 | 0.05% |